(CORNELL ENTERPRISE) February 19 2019 Journalist Dick Anderson conducted an interview with Dr. Gen Li, founder and president of Phesi. “Gen Li was an instructor of neuroscience at Weill Cornell Medicine in 1996 when he enrolled in the inaugural class of Johnson’s One-Year MBA program for students with advanced technology degrees. He recalls a team-building session when a peer said, “Gen, you have…
(CROWN CONGRESS) January 22 2019 Phesi is a proud sponsor and presenter at the 8th CROWN congress in Orlando, Florida. The CMO of Phesi, Dr. Paul Chew gives a talk titled “Smarter Trials = Faster Cures: 3 Things You Need to Get Right”. The presentation slides can be downloaded here. About the 8th CROWN congress This year’s CROWN Congress will…
(BUSINESS WIRE) October 10, 2018 EAST LYME, Conn. Phesi, a technology-enabled, data-driven provider of premier clinical development services, today announced it is a finalist for a 2018 Scrip Award, one of the pharmaceutical and biotech industries’ most prestigious honors. The company has been selected as one of six finalists in the Best Technological Development in Clinical Trials – Tech Sponsor-focused…
A news article by Melissa Fassbender is published on Outsourcing Pharma, with the following summary: The clinical development services provider Phesi is looking to patent its method and system for developing clinical trial protocols – which enables faster patient enrollment and study completion, says CEO. Read the full article on Outsourcing Pharma.
(BUSINESS WIRE) April 24, 2018 EAST LYME, Conn. Phesi, a technology-enabled, data-driven provider of premier clinical development services, today announced the addition of Paul Chew, MD, as its Chief Medical Officer (CMO). Dr. Chew also joins the Phesi Board of Directors, which was expanded in 2017 by the appointments of Annalisa Jenkins, MBBS, FRCP, and Steve Arlington, PhD. Phesi leverages the industry’s…